Canadian Society of Surgical Oncology
 

Annual Meetings

The Annual Meeting of the CSSO is held every Spring at the same time as the Canadian Cancer Trials Group (CCTG) Annual Meeting in Toronto. Please join us at the CSSO Annual Meeting where we showcase the research being done by Surgical Oncologists across Canada and listen to an Expert Invited Speaker on a current hot topic in Surgical Oncology. We also have a live Tumour Board filled with insight and entertainment. For members of the CSSO, this meeting is FREE of charge. All you need to do is pay your Annual Dues.

2025 CSSO Annual Spring Meeting - April 25, 2025

THEME : The treatment of solid cancers in the ERA of IMMUNOTHERAPY

NEW LOCATION: HILTON TORONTO HOTEL

There is a block of rooms available at a special rate - $319 (+taxes)/night. Click below to book a room.

DINNER FRIDAY NIGHT WILL BE AT STRATUS : TD South Tower, 79 Wellington St W tower 36th floor, Toronto, ON M5K 1J5 - Tickets for purchase at the time of Registration

ABSTRACT SUBMISSION DEADLINE IS: MARCH 3

GRANT DEADLINE IS : FEBRUARY 24, 2025 (see Home Page for details)

 
doctors-background-5.jpg

2025 Temple Lecturer - Dr. Vernon Sondak

Vernon Sondak, MD, FACS, Chair, Department of Cutaneous Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida

Dr. Sondak is Chair of the Department of Cutaneous Oncology at the H. Lee Moffitt Cancer Center and Research Institute in Tampa, Florida. He holds the Richard M. Schulze Family Foundation Distinguished Endowed Chair in Cutaneous Oncology, and is also a Professor in the Departments of Oncologic Sciences and Surgery at the University of South Florida Morsani College of Medicine. Since 2004, when he came to Tampa, the Cutaneous Oncology Clinic at Moffitt has grown into one of the largest multidisciplinary treatment centers for pediatric melanoma and related conditions in the world.

Dr. Sondak has been a leader in studies of surgical treatment of melanoma and other cutaneous malignancies, particularly in the application of sentinel lymph node biopsy and lymph node dissection to the staging and treatment of melanoma, and has been instrumental in training many surgical oncologists in these techniques over the years.

Dr. Sondak also has a strong research background: he served as Principal Investigator of the Moffitt Skin SPORE, a major NCI-funded “team science” grant conducting translational research in melanoma and other cutaneous malignancies. His research interests include surgical treatment of melanoma in adults and children; adjuvant (postoperative) and neoadjuvant (preoperative) therapy of melanoma; and evaluation of new therapies for patients with localized or disseminated melanoma.  

Dr. Walley Temple

walley-temple.jpg

Dr. Walley J. Temple was a Professor with the Departments of Oncology and Surgery with the Faculty of Medicine at the University of Calgary and the Tom Baker Cancer Centre. He retired from clinical practice in 2019 and is now appointed Professor Emeritus in Oncology.

He received his MD degree from Queen’s University, Kingston, Ontario, Canada, did a General Surgery Residency in Winnipeg at the University of Manitoba, Canada and completed his surgical oncology training at the Department of Surgery, School of Medicine at the University of Miami, Florida. He was an American Cancer Society Surgical Oncology Fellow and American Cancer Society Junior Faculty Fellow.

Dr. Temple is a Fellow of the Royal College of Physicians and Surgeons of Canada and of the American College of Surgeons. He moved to Calgary in 1983 to initiate surgical oncology development at the University of Calgary and the Tom Baker Cancer Centre and served as Chief of Surgical Oncology from 1983-2012. He was the clinical director of Cancer Surgery Alberta for many years. From 1986 to 1992 he was Chief of the Division of General Surgery and Director of the General Surgery Residency Training Program for the Department of Surgery. He was the James IV Association of Surgeons’ James IV Surgical Traveler in 1987, and past Presidents of the Calgary Society of Surgeons, the Canadian Society of Surgical Oncology, the World Federation of Surgical Oncology Society, and the Society of Pelvic Surgeons. He received the University of Calgary Students’ Union Teaching Excellence Award 1992. During the period of 1994 to 1998 he was involved in the University of Calgary’s International Development Program in Nepal for the MDGP Project. From 1994 to 2000 he was Chair of the Medical Skills Program with the Faculty of Medicine. Dr. Temple received a Diploma of Visiting Professor Emeritus Medical Faculty University of Ljubljana in Slovenia, 2002. He was awarded a University of Calgary Faculty of Medicine Smith Distinguished Achievement Award for 2005. He was the Director of the Surgical Oncology Residency Training Program until September 2006.

In 2011 he received a distinguished Service Award for the Department of Surgery . He was the Principal Investigator for the CPAC Surgical Synoptic Reporting Trials Project 2007– 2012 and the PI for the Canada Health Infoway Innovation project in Alberta for integrating the patient experience in the clinical management of the cancer patient.

His bibliography includes over 150 publications including journal articles and book chapters. He was the Editor-in-Chief of the Journal of Surgical Oncology and Seminars in Surgical Oncology for 12 years. His research interests included sarcoma, breast cancer, multidisciplinary management of advanced GI malignancy exploring the value of HIPEC for peritoneal malignancies, knowledge transfer using Synoptic Technology, helping physicians deal with adverse events and integrating PROS into everyday practice.

He retired from clinical practice in 2018. He continues to be active in global medicine and currently leads a 2 year Rotary funded cervical cancer screening and treatment project for 5000 women in rural Guatemala .

His personal pursuits include volunteering with Rotary, hiking, camping, horseback riding. Especially, and most importantly, he values family time with his partner, 4 children and 9 grandchildren.

Past Temple Lecturers

Ronald DeMatteo, MD, 2024

Brendan Moran, MD, 2023

Kurt Weiss, MD, 2022

Des Winter, MD, 2021

Charlotte Ariyan, MD, PhD - 2019

Chandrajit P. Raut, M.D., M.Sc. - 2018

Janice Pasieka MD, FRCSC, FACS - 2017

Han-Kwang Yang - 2016

Walley J Temple MD, FRCSC, FACS - 2015

Carol Swallow, MD, PhD, FRCSC, FACS - 2014

Kelly M. McMasters, MD, PhD - 2013

Matthew J. C. Ellis, MB, BChir, PhD - 2012

Shreyaskumar R. Patel, MD - 2011

Vic J. Verwaal, MD, PhD - 2010

Jeffrey F. Moley, MD - 2009

Fairooz Kabbinavar, MD - 2008

The Program for the 2025 Spring Meeting coming soon!

Overall program learning objectives:

By the end of this event, the learner will be able to:

  1. Describe the breadth of academic inquiry being undertaken by surgical trainees and faculty involved in cancer care.

  2. Describe the impact and role that immunotherapy has played in cancer over the years.

  3. Describe how determining the sequence of treatments can affect cancer outcomes.

  4. Identify opportunities for collaboration between Surgical Oncologists locally, nationally and internationally.

ABSTRACT WINNERS AT CSSO 2024

RESEARCH GRANT: Dr. David Wai Lim

Project Title: Molecular profiling and characterization of the tumour-immune microenvironment in invasive lobular breast carcinoma

TOP LONG ABSTRACT: Dr. Adom Bondzi-Simpson

Abstract Title: Association of socioeconomic status and the receipt of adjuvant chemotherapy in stage III colon cancer: a population-based cohort study

RUNNER UP: Dr. Tiago Ribeiro

Abstract Title: Trends in hospitalization in patients with malignant bowel obstructions secondary to incurable gastrointestinal cancer: A retrospective cohort study using multi-state models

TOP SHORT ABSTRACT: Dr. Colleen Kerrigan

Abstract Title: Addressing Global Inequities in Breast Cancer Genetic Testing, Counselling, and Management Among Breast Cancer Patients in Nigeria - A Healthcare Provider Educational Program

ABSTRACT WINNERS AT CSF 2024

TOP ORAL PRESENTATIONS

Dr. Janyssa Charbonneau

Abstract Title: Predictive value of C-Reactive Protein for Infectious Complications after Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: A Single-Center Prospective Study

Dr. Dejan Vidovic

Abstract Title: Intralesional Interleukin-2 Based Therapy is Effective in the Treatment of High-Risk Cutaneous Squamous Cell Carcinoma

Dr. Ekaterina Kouzmina

Abstract Title: Axillary Surgery after Neoadjuvant Chemotherapy: Population-Based Trends over Time

Dr. Georgia Nelson

Abstract Title: Axillary Lymph Node Management of Clinically N0 Male Breast Cancer: A Systematic Review

Dr. Sean Bennett

Abstract Title: Small Bowel Cancers: A Population-Based Analysis of Epidemiology, Treatment and Outcomes in Ontario, Canada from 2005-2020

Canadian Surgery Forum


CSSO at the CSF

Every year CSSO creates an educational Program for CSF. Please join us in Montreal for the 2025 Canadian Surgical Forum.

What to expect at CSF 2025 (COMING SOON): 

Visit the Canadian Surgery Forum online to learn more about our destination, keynote speakers and special events.

www.canadiansurgeryforum.com


Shibata Lecture

Please come see our invited guest and Shibata Lecturer Dr. Alessandro Gronchi. He will describe how a practice in treating a rare cancer can evolve over time to lead to an International Collaboration.

Alessandro Gronchi MD received his MD degree from Milan University in 1992, completed his residency training in General Surgery in 1997 and a fellowship in Surgical Oncology in 1998. He holds the National Scientific qualification for full professor of General Surgery. He is chief of the Sarcoma Service since 2001 and chair of the department of Surgery since 2022 at the National Cancer Institute – Milan – Italy.

He is involved in all institutional research activities on sarcoma, which include neoadjuvant therapies in extremity and retroperitoneal sarcomas, new targets for specific STS types, genomic characterization of DF and its impact in tumor progression, mechanisms of resistance to therapy in GIST. He is the Principal Investigator of several Italian and International trials on STS, DF and GIST.

He serves as member of the board of directors of the Italian Sarcoma Group, member of the board of directors of the European Society of Surgical Oncology 2020-2024; international representative on the executive council of the SSO 2021-2024; member of the Sarcoma Task Force of the European Society for Medical Oncology. He was chair of the EORTC Soft Tissue and Bone Sarcoma Group (2015-2017), president of the Connective Tissue Oncology Society (2016); president of the Italian Society of Surgical Oncology (2019-2021). He is member of the European Surgical Association, the American Society of Clinical Oncology and honorary member of the Polish Society of Surgical Oncology. He is one of the initiators of a global collaborative effort on retroperitoneal sarcoma (Trans-atlantic Australasian RetroPeritoneal Sarcoma Working Group, TARPSWG), which involves over 180 institutions worldwide. Dr. Gronchi has authored more than 500 scientific publications (Scopus HIndex 96), serves as Associate Editor of Annals of Surgical Oncology, Journal of Surgical Oncology, Critical Reviews in Oncology/Hematology, Therapeutics Advances in Medical Oncology; Updates in Surgery.

 

Dr. Henry Shibata

Henry Ryusuke Shibata FACS, FRCS(C) MD (Hiroshima); MSc (McGill)

Henry Ryusuke Shibata FACS, FRCS(C) MD (Hiroshima); MSc (McGill)

Dr. Henry Shibata is the founder of the Canadian Society of Surgical Oncology. He has had a long and illustrious career. Born Vancouver April 4, 1930, Henry Shibata moved to Japan after World War II, graduated from the Hiroshima University School of Medicine in l955 and spent a year at the Hiroshima Atomic Bomb Casualty Commission. In 1961, he came to Montreal and completed his training at the Royal Victoria Hospital before joining McGill. He co-founded McGill's Melanoma Clinic in 1972 and founded Canada's first training program in general surgical oncology in 1978. Shibata was founding president of the Canadian Society of Surgical Oncology. In 2002, the Government of Japan awarded him with the Order of the Sacred Treasure, Gold Rays with Rosette medal.  (Source McGill Reporter) May 18, 2006 - Volume 38 Number 17. This honour is in recognition of his efforts in fostering academic relationships in medicine between Canada and Japan and for meritorious service to the Japanese community of Montreal. Henry was co-founder of the Montreal Academy Club, dedicated to aiding young Japanese students, clinicians and researchers to further their studies, mainly at McGill in medicine. He has been the permanent president of this organization for the past 15 years. (Source Alum notes-McGill news Summer 2003)

After completing his surgical residency oat the Royal Victoria Hospital under the guidance of Dr. Lloyd MacLean he joined McGill University’s Division of General Surgery. He rapidly progressed to Full Professor in 1989 and was the Director of the Division of Surgical Oncology at McGill University from 1988 to 2000. He was Associate Chairman from June 2000 to June 2001. He served a decade on the Committee on Patient Care and Research of the Commission on Cancer. He was Chairman of the Committee on Surgical Oncology of the American Association for Cancer Education from 1983 to 1986. He was President of the Canadian Oncology Society from 1989-91 and the founding President of the Canadian Society of Surgical Oncology from 1988 to 1991.

Dr. Shibata has played a pivotal role in the NSABP, serving as member of the Executive Committee from 1980 to 1983 and as a member of the Board of Directors from 1997 to 2001. He has given over 75 presentations world wide, including talks on breast cancer, melanoma, and colorectal cancer in Hungary, Japan, Venezuela and India. Dr. Shibata has had over 80 peer reviewed publications. He is Professor Emeritus of Surgery and Oncology at  McGill University since Jan 2006

The Canadian Society of Surgical Oncology as well as the Canadian Surgical Oncology Community is indebted to Dr. Shibata’s foresight and tenaciousness in advancing our Specialty.

Past Shibata lectures

Sandra Wong, 2024

Tsuyoshi Konishi 2023

Alexandre Heriot 2022

Paul Mansfield 2021

Shelley Hwang 2019

David Bartlett 2018

Vernon Sondak 2017

Geoff Dunne 2016

Karl Bilimoria 2015

H.D. Bear 2014

Ron DeMatteo 2013

 

David McCready 2011

Martha Zeiger 2010

Steven Curley 2009

Patrick Borgen 2008 moved to CSF

Vernon Sondak 2007

Monica Morrow 2006

Robin Macleod 2005

George P. Browman 2004

 

Roy Smith 2003

Yuman Fong 2002

David Krag 2001

Merrick Ross 2000

Walley Temple 1999

Judah Folkman 1998

Glenn Steele 1997

Robery Kerbel 1996

Ian Tannock 1995


What would you like CSSO to Cover at CSF?

 
 

Canadian Surgical Forum

Sept 17-20, 2025 - Montreal, Quebec

 
 

American College Surgeons Clinical Congress

Oct 4-7, 2025 - Chicago, Illinois

 
 

Connective Tissue Oncology Society Annual Meeting

November 12 - 15, 2025 - Boca Raton, Florida

 
 

San Antonio Breast Cancer Symposium

Dec 9-12, 2025 - San Antonio, Texas

 
 
 

Canadian Melanoma Conference

Feb 20-22, 2025 - Vancouver, British Columbia

 
 

Society of Surgical Oncology Annual Cancer Symposium

March 27-29, 2025 - Tampa, Florida

 
 

American HPB Association

March 20-23, 2025 - Miami, Florida

 
 

American Society of Breast Surgeons Annual Meeting

Apr 30- May 4, 2025 - Las Vegas, Nevada

 
 

American Society of Clinical Oncology Annual Meeting

May 30-June 3, 2025 - Chicago, Illinois

 
 

Toronto International Sarcoma Symposium (every 2 years)

May 9, 2025 - Toronto, Ontario